Oncology News | pharmaphorum

News

New trial data sets up a filing for Nuvalent's new-generation ROS1 inhibitor in NSCLC, although it has an uphill battle to catch rival Nuvation.

News

AZ and Daiichi Sankyo have claimed FDA approval for Datroway in lung cancer after switching indications for the TROP2-directed drug.

News

The NHS has started a pilot project that will sift through patient records to try to detect people at risk of pancreatic cancer.

News

Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.

News

Combining Johnson & Johnson's multiple myeloma therapies Talvey and Tecvayli shows promise in a hard-to-treat form of multiple myeloma.

News

England is the first country in the world to make GSK's relaunched anti-BCMA drug Blenrep available to patients with multiple myeloma.